Lactoferricin peptides permeabilize E. coli membranes in less than 3 seconds and accumulate inside cells at concentrations of 80–100 mM, but membrane damage alone doesn't kill bacteria — intracellular disruption is the key.
<3 seconds to breach membranesLactoferricins permeabilized E. coli membranes in under 3 seconds and accumulated to 80–100 mM inside cells, but membrane damage alone was insufficient for killing — intracellular disruption is the lethal mechanism.
What the researchers found
Using millisecond time-resolved synchrotron small-angle X-ray scattering, researchers captured the real-time response of E. coli to lactoferricin-derived AMPs across length scales from whole cells down to lipid packing. Key findings:
1. The peptides permeabilized the cytosolic membrane in less than 3 seconds — much faster than previously considered.
2. Final intracellular peptide concentrations reached ~80–100 mM, suggesting efficient obstruction of physiologically important processes as the primary killing mechanism.
3. Membrane damage and leakage occurred even at sublethal concentrations, showing that membrane permeabilization is a necessary but not sufficient condition for killing.
4. The most efficient peptide studied excelled in both speed of membrane permeabilization and lowest intracellular concentration needed to inhibit bacterial growth.
Why it matters
This study fundamentally changes our understanding of how antimicrobial peptides kill bacteria. The longstanding assumption was that membrane disruption is the primary killing mechanism, but these results show it's actually what happens after the peptides get inside that matters most. This insight is crucial for designing better antimicrobial peptides — rather than focusing solely on membrane-disrupting ability, researchers should also optimize intracellular activity.
How the study worked
Researchers used millisecond time-resolved synchrotron small-angle X-ray scattering (SAXS) at a synchrotron facility to observe the real-time structural changes in living E. coli upon exposure to lactoferricin-derived antimicrobial peptides. A multiscale scattering data analysis was coupled with biophysical assays for peptide partitioning between bacterial membranes and the surrounding medium. This allowed simultaneous observation at both microscopic (cell-level) and nanoscopic (lipid-level) scales.
What this study cannot tell us
The study focused exclusively on E. coli (a Gram-negative bacterium) and results may differ for Gram-positive bacteria, which have different membrane architectures. The synchrotron experiments were performed under specific laboratory conditions that may not fully replicate physiological environments. The exact intracellular processes disrupted by the accumulated peptides were not identified. The study used lactoferricin-derived peptides specifically, and the findings may not generalize to all antimicrobial peptide classes.
How to read the evidence
This is a rigorous biophysical study published in eLife using advanced synchrotron X-ray scattering technology. The experimental approach provides unprecedented temporal resolution for observing peptide-bacteria interactions. However, the findings are mechanistic and in vitro, focused on E. coli.
When this study was published
Published in 2022, this study represents the state of the art in real-time biophysical analysis of antimicrobial peptide mechanisms and remains highly relevant to current AMP research.
The bigger picture
Antimicrobial peptides are widely studied as alternatives to conventional antibiotics, but their exact killing mechanisms have been debated for decades. This study, using cutting-edge synchrotron technology to watch the process in real time, provides the clearest picture yet. The finding that membrane damage is necessary but not sufficient for killing challenges a central dogma in the field and redirects attention toward intracellular targets — potentially opening new strategies for designing more effective antimicrobial peptides.
Questions still open
- Which specific intracellular processes are disrupted when lactoferricins accumulate at 80–100 mM concentrations inside bacteria?
- Do other antimicrobial peptide families also kill primarily through intracellular disruption rather than membrane damage?
- Could antimicrobial peptides be engineered to optimize intracellular accumulation rather than membrane-disrupting potency?
Common questions
What are lactoferricins?
Why doesn't punching holes in bacterial membranes kill them?
Read the original research
Lactoferricins impair the cytosolic membrane of Escherichia coli within a few seconds and accumulate inside the cell.
eLife, 11
Citation
Semeraro, Enrico F; Marx, Lisa; Mandl, Johannes; Letofsky-Papst, Ilse; Mayrhofer, Claudia; Frewein, Moritz P K; Scott, Haden L; Prévost, Sylvain; Bergler, Helmut; Lohner, Karl; Pabst, Georg. (2022). Lactoferricins impair the cytosolic membrane of Escherichia coli within a few seconds and accumulate inside the cell.. eLife, 11. https://doi.org/10.7554/eLife.72850